Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Lung Disease

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects2003 · 10,829 citations
2. 2RELATIONSHIP BETWEEN IN VITRO CLARITHROMYCIN SUSCEPTIBILITY AND SPUTUM CULTURE CONVERSION WITH ADD-ON AMIKACIN LIPOSOME INHALATION SUSPENSION (ALIS) FOR TREATMENT OF REFRACTORY MYCOBACTERIUM AVIUM COMPLEX (MAC) LUNG DISEASE2018 · 1 citations
3. 3International Conference On Harmonisation Of Technical Requirements For Registration Of Pharmaceuticals For Human Use2010 · 2,589 citations
4. 4Durability of culture conversion in patients receiving Amikacin Liposome Inhalation Suspension (ALIS) for treatment-refractory Mycobacterium avium complex lung disease (MAC-LD) in the CONVERT study2019 · 3 citations
5. 5World Medical Association Declaration of Helsinki2013 · 29,661 citations